Exploring a New Cell-Based Therapy to Treat Mesothelioma
|

Exploring a New Cell-Based Therapy to Treat Mesothelioma

ByHolly Zink

Mesothelioma, an asbestos-related cancer, can be very difficult to treat. But researchers have a new model for a cell-based therapy with Paclitaxel. New results were recently published in Biochemical Pharmacology. Mesothelioma Treatment Malignant mesothelioma is a very aggressive cancer. Pleural mesothelioma is a type of cancer that develops from the thin layer of tissue that covers the lungs and chest wall. It can often take around 40 years for pleural mesothelioma to be diagnosed. Imaging studies such as X-rays or CT scans may help in the diagnosis, but a tissue biopsy usually confirms the disease. In this latest study, researchers used two tools. They used a group of human cells called mesenchymal stromal cells. And, they used Paclitaxel, a medicine…

Paclitaxel May Prevent Metastatic Peritoneal Mesothelioma in High Risk People
| | |

Paclitaxel May Prevent Metastatic Peritoneal Mesothelioma in High Risk People

ByAlex Strauss

Administering the chemotherapy drug paclitaxel directly into the abdomen of people with mesothelioma might offer a way to prevent metastatic peritoneal mesothelioma. That is the premise of a recent article by Dr. Paul Sugarbaker in the Journal of Gastrointestinal Oncology. Dr. Sugarbaker is a global expert in peritoneal mesothelioma. He works at MedStar Washington Hospital in Washington, DC. Metastatic peritoneal mesothelioma is when mesothelioma cells spread. They move from their original spot to other parts of the abdomen. Paclitaxel can help prevent new tumors in people who already have some metastases. In his new article, Dr. Sugarbaker says the evidence suggests that it might also work to keep metastases from forming. Metastatic Peritoneal Mesothelioma Treatment Malignant mesothelioma is a cancer…